Terms: = Cervical cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Prognosis
30 results:
1. Pathogenomics model for personalized medicine in cervical cancer: Cross-talk of gene expressions and pathological images related to oxidative stress.
Li J; Chen S; Wu J; Liu X; Liu H; Liu Y; Zhu Z
Environ Toxicol; 2024 Feb; 39(2):751-767. PubMed ID: 37755325
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer.
Li J; Wan C; Li X; Quan C; Li X; Wu X
J Transl Med; 2023 Sep; 21(1):647. PubMed ID: 37735483
[TBL] [Abstract] [Full Text] [Related]
3. Infection pattern and immunological characteristics of Epstein-Barr virus latent infection in cervical squamous cell carcinoma.
Zuo Y; Xiao H; Lv D; Huang M; Wang L; Liu J; Zhang K; Shen J; Wang Z; Wu Q; Xu Y
J Med Virol; 2023 Apr; 95(4):e28717. PubMed ID: 37184049
[TBL] [Abstract] [Full Text] [Related]
4. RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer.
Wang Y; Mao Y; Wang C; Jiang X; Tang Q; Wang L; Zhu J; Zhao M
Ann Med; 2023 Dec; 55(1):2190618. PubMed ID: 37042849
[TBL] [Abstract] [Full Text] [Related]
5. Dynamics in the expression of programmed death ligand 1 and cluster of differentiation 163 in the tumor microenvironment of uterine cervical cancer: a single-center retrospective study.
Miyata Y; Ogo E; Abe T; Hirata H; Tsuda N; Ushijima K; Kawahara A; Akiba J; Obara H; Kakuma T
Radiat Oncol; 2023 Feb; 18(1):40. PubMed ID: 36823665
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic, prognostic, and immunological roles of CD177 in cervical cancer.
Liao W; Li W; Li Y; Liu T; Wang Y; Feng D; Shen F
J Cancer Res Clin Oncol; 2023 Jan; 149(1):173-189. PubMed ID: 36352147
[TBL] [Abstract] [Full Text] [Related]
7. Laparoscopic Radical Hysterectomy Combined with Neoadjuvant Chemotherapy for cervical cancer Patients Effectively Improves Immune Function.
Liu M; Wang H; Du S; Li W; Xuan F; Zhao Y; Li N
Dis Markers; 2022; 2022():3611174. PubMed ID: 36157208
[TBL] [Abstract] [Full Text] [Related]
8. Immune checkpoint blockades in gynecological cancers: A review of clinical trials.
Peng H; He X; Wang Q
Acta Obstet Gynecol Scand; 2022 Sep; 101(9):941-951. PubMed ID: 35751489
[TBL] [Abstract] [Full Text] [Related]
9. Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?
Shiri Aghbash P; Shirvaliloo M; Khalo Abass Kasho A; Alinezhad F; Nauwynck H; Bannazadeh Baghi H
Int Immunopharmacol; 2022 Jul; 108():108896. PubMed ID: 35640377
[TBL] [Abstract] [Full Text] [Related]
10. Signature involved in immune-related lncRNA pairs for predicting the immune landscape of cervical cancer.
Liu X; Wang Z; Wang L; Wang Y; Wang Y; Yang S; Zhang Y
Int J Biol Markers; 2022 Jun; 37(2):191-199. PubMed ID: 35435763
[TBL] [Abstract] [Full Text] [Related]
11. Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancer.
Liu S; Li R; Liu Q; Sun D; Yang H; Pan H; Wang L; Song S
Cancer Biomark; 2022; 33(2):249-259. PubMed ID: 35213357
[TBL] [Abstract] [Full Text] [Related]
12. Constructing a Novel Signature Based on Immune-Related lncRNA to Improve prognosis Prediction of cervical Squamous Cell Carcinoma Patients.
Lv X; Liu L; Li P; Yuan Y; Peng M; Jin H; Qin D
Reprod Sci; 2022 Mar; 29(3):800-815. PubMed ID: 35075611
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma.
Liao C; Wang A; Ma Y; Liu H
Medicine (Baltimore); 2021 Oct; 100(40):e27473. PubMed ID: 34622876
[TBL] [Abstract] [Full Text] [Related]
14. Assessment of cervical vascularization density in patients with locally advanced squamous cell cervical carcinoma evaluated in colour Doppler and power Doppler functions.
Tomalczyk A; Tomasik B; Fijuth J; Moszynska-Zielinska M; Gottwald L
Arch Gynecol Obstet; 2022 Apr; 305(4):955-961. PubMed ID: 34586470
[TBL] [Abstract] [Full Text] [Related]
15. Mixed endocervical adenocarcinoma and high-grade neuroendocrine carcinoma of the cervix: A case report.
Teoman G; Ersoz S
Indian J Pathol Microbiol; 2021; 64(1):174-176. PubMed ID: 33433435
[TBL] [Abstract] [Full Text] [Related]
16. Influences of neoadjuvant chemotherapy on clinical indicators, prognosis and neutrophil/lymphocyte ratio of stage IB2-IIB cervical cancer.
Wang X; Chen J; Sun W; Zhu M; Li D; Chen G
J BUON; 2020; 25(2):757-763. PubMed ID: 32521864
[TBL] [Abstract] [Full Text] [Related]
17. The immune checkpoints ctla-4 and PD-L1 in carcinomas of the uterine cervix.
Karpathiou G; Chauleur C; Mobarki M; Peoc'h M
Pathol Res Pract; 2020 Jan; 216(1):152782. PubMed ID: 31862202
[TBL] [Abstract] [Full Text] [Related]
18. The Role of Biomarkers for the Prediction of Response to Checkpoint Immunotherapy and the Rationale for the Use of Checkpoint Immunotherapy in cervical cancer.
Otter SJ; Chatterjee J; Stewart AJ; Michael A
Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):834-843. PubMed ID: 31331818
[TBL] [Abstract] [Full Text] [Related]
19. Pathways- and epigenetic-based assessment of relative immune infiltration in various types of solid tumors.
Bacolod MD; Barany F; Pilones K; Fisher PB; de Castro RJ
Adv Cancer Res; 2019; 142():107-143. PubMed ID: 30885360
[TBL] [Abstract] [Full Text] [Related]
20. Cutaneous metastases from neuroendocrine carcinoma of the cervix-An unusual metastatic lesion from an uncommon malignancy.
Devnani B; Kumar R; Pathy S; Phulware RH; Mathur S; Kumar L
Curr Probl Cancer; 2018 Sep; 42(5):527-533. PubMed ID: 29937242
[TBL] [Abstract] [Full Text] [Related]
[Next]
